Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase NA 1Phase 3 1

Status

Recruiting 2Completed 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Breast Neoplasms 36Rectal Neoplasms 23Stomach Neoplasms 19Triple Negative Breast Neoplasms 16Colorectal Neoplasms 14Neoplasm Metastasis 12Adenocarcinoma 9Parkinson Disease 4, Autosomal Dominant Lewy Body 7Pancreatic Neoplasms 7Esophageal Neoplasms 7Adenocarcinoma Of Esophagus 7Nasopharyngeal Carcinoma 6Colonic Neoplasms 6Biliary Tract Neoplasms 6Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Spinocerebellar Degenerations 2Pathologic Complete Response 2Ovarian Neoplasms 2Neoplasm, Residual 2Locally Advanced Rectal Cancer 2Cholangiocarcinoma 2Carcinoma 2Bile Duct Neoplasms 2Anus Neoplasms 2Advanced Solid Tumour 2Somatostatinoma 1Solid Tumors 1

Interventions

Gemcitabine 53130-nm albumin-bound paclitaxel 30Specimen Handling 27Albumin-Bound Paclitaxel 23Magnetic Resonance Spectroscopy 20Leucovorin 19Fluorouracil 19Irinotecan 17Taxes 16Oxaliplatin 16Biopsy 16pembrolizumab 13Radiosurgery 8Cyclophosphamide 8Cisplatin 8fludarabine 7Cetuximab 7Capecitabine 7irinotecan sucrosofate 6Nivolumab 6Carboplatin 6durvalumab 5dehydroftorafur 5Pemetrexed 5Ipilimumab 5Erlotinib Hydrochloride 5Drug Therapy 5Blood Specimen Collection 5olaparib 4defactinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Capecitabine × 90 days × Clear all
NCT01972919 2026-05-12

MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer

Medical College of Wisconsin

Phase 2 Active not recruiting
23 enrolled 8 charts
Gastrointestinal

Pancreatic Neoplasms

NCT05415917 2026-05-07

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT03523312 2026-05-06

MAIBE

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
47 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06958328 2026-05-04

LAP100

NRG Oncology

Phase 3 Recruiting
356 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00885066 2026-04-23

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Centre Antoine Lacassagne

Phase 1 Completed
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03403049 2026-04-13

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Montefiore Medical Center

Phase 1 Completed
14 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT04894643 2026-03-20

PARC

EBG MedAustron GmbH

Phase NA Recruiting
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡